Market-Moving News for June 29th
Portfolio Pulse from Benzinga Newsdesk
RenovoRx (RNXT) announced positive interim Phase III data showing RenovoGem™ delays cancer progression by eight months in locally advanced pancreatic cancer. Joby (JOBY) received a $100 million investment as it expands its partnership with SK Telecom. Kintara Therapeutics (KTRA) was awarded a $2.0 million National Institutes of Health SBIR grant to support the clinical development of REM-001.
June 29, 2023 | 12:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Joby has received a $100 million investment as it expands its partnership with SK Telecom.
Securing a significant investment often leads to a positive impact on the stock price as it provides the company with additional resources for growth.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Kintara Therapeutics has been awarded a $2.0 million National Institutes of Health SBIR grant to support the clinical development of REM-001.
Receiving a grant for clinical development is a positive sign as it not only provides financial support but also validates the potential of the product.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
RenovoRx's RenovoGem™ has shown promising results in delaying cancer progression.
Positive clinical trial results often lead to an increase in stock price as it indicates potential future revenue from the product.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100